OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OABI is expected to report earnings to rise 5.18% to -11 cents per share on August 06
Q2'26
Est.
$-0.12
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.03
The last earnings report on March 04 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 552.05K shares outstanding, the current market capitalization sits at 334.89M.